ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 632620 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 632620; 2) Community: the network communities that were significantly associated with the response to NSC 632620; 3) Molecule: the relationships between components within communities and NSC 632620; 4) MDR: the compounds that were significantly associated with the NSC 632620.

NSC Compound Enrichment Correlation
NSC 724628 4,11-bis[[2-(dimethylamino)ethyl]-amino]-1H-naphtho[2,3-f]in dole-5,10-dione 0.0241085022307781 0.57757219
NSC 744075 Null 0.0241085022307781 0.41200886
NSC 758662 Lovastatin [USAN] 0.0241085022307781 -0.016746397
NSC 93134 HELLEBRIN 0.0241085022307781 0.30238598
NSC 102817 Germacra-1(10),11(13)-diene-12,14-dioic acid, 4,5.alpha.-epoxy-2.beta.,6.alpha.,8.alpha.-trihydroxy-, 12,6:14,2-dilactone, 3-methylcrotonate (8CI) 0.0244632509325736 0.23675704
NSC 113951 6-Bromotoyocamycin 0.0244632509325736 0.5020723
NSC 330500 Macbecin II 0.0244632509325736 0.24198977
NSC 39202 Cyclohexanone, 2,6-bis(piperidinomethyl)- 0.0244632509325736 0.26146891
NSC 626163 Discorhabdin C-nitrodienone . TFA 0.0244632509325736 0.29414214
NSC 628911 3-(2-N,N-diethylaminoethylamino)-7-nitro-1,2,4- benzotriazine 1,4-dioxide. Trifluoroacetate 0.0244632509325736 0.46023137
Total:128  Current:82    [First] [Prev] [Next] [Last]